Patents by Inventor Tzu-Ling Tseng
Tzu-Ling Tseng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240136472Abstract: A semiconductor light-emitting device includes a semiconductor stack including a first semiconductor layer and a second semiconductor layer; a first reflective layer formed on the first semiconductor layer and including a plurality of vias; a plurality of contact structures respectively filled in the vias and electrically connected to the first semiconductor layer; a second reflective layer including metal material formed on the first reflective layer and contacting the contact structures; a plurality of conductive vias surrounded by the semiconductor stack; a connecting layer formed in the conductive vias and electrically connected to the second semiconductor layer; a first pad portion electrically connected to the second semiconductor layer; and a second pad portion electrically connected to the first semiconductor layer, wherein a shortest distance between two of the conductive vias is larger than a shortest distance between the first pad portion and the second pad portion.Type: ApplicationFiled: December 29, 2023Publication date: April 25, 2024Inventors: Chao-Hsing CHEN, Jia-Kuen WANG, Tzu-Yao TSENG, Tsung-Hsun CHIANG, Bo-Jiun HU, Wen-Hung CHUANG, Yu-Ling LIN
-
Patent number: 10101340Abstract: Described is a method of detecting a protein fragment in a urine sample and a serum sample. The protein fragment is a urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, or serum osteopontin fragment. The urine sample and the serum sample are obtained from the same individual.Type: GrantFiled: May 24, 2013Date of Patent: October 16, 2018Assignee: Bio Preventive Medicine Corp.Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Patent number: 9983216Abstract: Identification of urokinase-type plasminogen, matrix metalloproteinase 9, and ?-2-microglobulin as novel biomarkers associated with liver fibrosis and uses thereof in diagnosing and staging liver fibrosis.Type: GrantFiled: September 15, 2017Date of Patent: May 29, 2018Assignee: Industrial Technology Research InstituteInventors: Tzu-Ling Tseng, Hung-Yi Li, Yen-Peng Li, Angelina Huai-Lo Lee, Yi-Chen Liu, Ping-Fu Cheng, Wei-Ya Lin, Hong-Zen Yeh
-
Publication number: 20180003722Abstract: Identification of urokinase-type plasminogen, matrix metalloproteinase 9, and ?-2-microglobulin as novel biomarkers associated with liver fibrosis and uses thereof in diagnosing and staging liver fibrosis.Type: ApplicationFiled: September 15, 2017Publication date: January 4, 2018Inventors: Tzu-Ling Tseng, Hung-Yi Li, Yen-Peng Li, Angelina Huai-Lo Lee, Yi-Chen Liu, Ping-Fu Cheng, Wei-Ya Lin, Hong-Zen Yeh
-
Patent number: 9791460Abstract: Identification of urokinase-type plasminogen, matrix metalloproteinase 9, and ?-2-microglobulin as novel biomarkers associated with liver fibrosis and uses thereof in diagnosing liver fibrosis.Type: GrantFiled: December 13, 2013Date of Patent: October 17, 2017Assignee: Industrial Technology Research InstituteInventors: Tzu-Ling Tseng, Hung-Yi Li, Yen-Peng Li, Angelina Huai-Lo Lee, Yi-Chen Liu, Ping-Fu Cheng, Wei-Ya Lin, Hong-Zen Yeh
-
Patent number: 9442120Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: GrantFiled: June 7, 2013Date of Patent: September 13, 2016Assignee: Industrial Technology Research InstituteInventors: Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Mary Ya-Ping Yeh, Yi-Ting Chen, Chwei-Shiun Yang
-
Publication number: 20140106370Abstract: Identification of urokinase-type plasminogen, matrix metalloproteinase 9, and ?-2-microglobulin as novel biomarkers associated with liver fibrosis and uses thereof in diagnosing liver fibrosis.Type: ApplicationFiled: December 13, 2013Publication date: April 17, 2014Applicant: Industrial Technology Research InstituteInventors: Tzu-Ling Tseng, Hong-Yi Li, Ye-Peng Li, Angelina Huai-Lo Lee, Yi-Chen Liu, Ping-Fu Cheng, Wei-Ya Lin, Hong-Zen Yeh
-
Publication number: 20130266976Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: ApplicationFiled: June 7, 2013Publication date: October 10, 2013Inventors: Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Mary Ya-Ping Yeh, Yi-Ting Chen, Chwei-Shiun Yang
-
Publication number: 20130252267Abstract: Described are uses of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: ApplicationFiled: May 24, 2013Publication date: September 26, 2013Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Patent number: 8476077Abstract: Disclosed is use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: GrantFiled: December 15, 2010Date of Patent: July 2, 2013Assignee: Industrial Technology Research InstituteInventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Patent number: 8470547Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: GrantFiled: December 16, 2010Date of Patent: June 25, 2013Assignee: Industrial Technology Research InstituteInventors: Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Mary Ya-Ping Yeh, Yi-Ting Chen, Chwei-Shiun Yang
-
Patent number: 8465980Abstract: Disclosed is use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: GrantFiled: January 27, 2010Date of Patent: June 18, 2013Assignee: Industrial Technology Research InstituteInventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Patent number: 8076089Abstract: Biomarkers for liver diseases and method for using the same are provided. For detecting liver cirrhosis and liver cancer, the biomarkers are selected from any one of the amino acid sequences with SEQ ID NO:1 to SEQ ID NO:24 or derivatives or fragments or variants or the combination thereof or the antibodies against the amino acid sequences. Then the biomarkers are further developed into detection kits, such that by detecting the existence of autoantibodies or autoantigens in screened specimens, liver diseases are detected with higher accuracy and sensitivity.Type: GrantFiled: April 20, 2010Date of Patent: December 13, 2011Assignee: Industrial Technology Research InstituteInventors: Tzu Ling Tseng, Ping Fu Cheng
-
Patent number: 7972785Abstract: The present invention provides a method for detecting liver fibrotic injury, including fibrosis and/or cirrhosis, by assaying biological samples for differential expression of at least one gene encoding a protein chosen from SEQ ID NO: 1-SEQ ID NO: 63 and human orthologs thereof, wherein differential expression of at least one gene suggests the presence of liver fibrosis or cirrhosis. The invention also provides a kit containing nucleic acid probes or antibodies for detecting liver fibrosis and/or cirrhosis by assaying the differential expression of proteins encoded by SEQ ID NO: 1-SEQ ID NO: 63 and human orthologs thereof.Type: GrantFiled: January 23, 2007Date of Patent: July 5, 2011Assignees: Industrial Technology Research Institute (ITRI), National Health Research Institutes (NHRI)Inventors: Hui-Chu Hsieh, Tzu-Ling Tseng, Li-Jen Su, Chi-Ying Huang, Shih-Lan Hsu
-
Publication number: 20110086371Abstract: Use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: ApplicationFiled: December 20, 2010Publication date: April 14, 2011Applicant: Industrial Technology Research Institute(ITRI)Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Publication number: 20110086372Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: ApplicationFiled: December 20, 2010Publication date: April 14, 2011Applicant: Industrial Technology Research Institute(ITRI)Inventors: Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Yi-Ting Chen, Chwei-Shiun Yang
-
Publication number: 20110079077Abstract: Use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: ApplicationFiled: December 15, 2010Publication date: April 7, 2011Applicant: Industrial Technology Research Institute(ITRI)Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Publication number: 20110081668Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: ApplicationFiled: December 16, 2010Publication date: April 7, 2011Applicant: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE(ITRI)Inventors: MARY YA-PING YEH, TZU-LING TSENG, CHING-FANG LU, WEI-YA LIN, TSAI-WEI HSU, YI-TING CHEN, CHWEI-SHIUN YANG
-
Publication number: 20110081667Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: ApplicationFiled: December 15, 2010Publication date: April 7, 2011Applicant: Industrial Technology Research Institute(ITRI)Inventors: Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Yi-Ting Chen, Chwei-Shiun Yang
-
Publication number: 20100261209Abstract: Biomarkers for liver diseases and method for using the same are provided. For detecting liver cirrhosis and liver cancer, the biomarkers are selected from any one of the amino acid sequences with SEQ ID NO:1 to SEQ ID NO:24 or derivatives or fragments or variants or the combination thereof or the antibodies against the amino acid sequences. Then the biomarkers are further developed into detection kits, such that by detecting the existence of autoantibodies or autoantigens in screened specimens, liver diseases are detected with higher accuracy and sensitivity.Type: ApplicationFiled: April 20, 2010Publication date: October 14, 2010Applicant: Industrial Technology Research InstituteInventors: Tzu-Ling TSENG, Ping-Fu Cheng